NNFTF yields 2.35% · PFE yields 6.20%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, NNFTF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NNFTF + PFE for your $10,000?
Nanofilm Technologies International Limited, together with its subsidiaries, provides nanotechnology solutions in Singapore, China, Japan, and Vietnam. The company operates through three segments: Advanced Materials, Industrial Equipment, and Nanofabrication. The Advanced Materials segment offers advanced materials through surface solution services based on its vacuum coating technologies and processes. The Industrial Equipment segment manufactures and sells turnkey equipment systems comprising coating equipment, cleaning lines, and automation systems that are installed at its customers' production lines. This segment also provides customized operating software for its systems and training, as well as spare-parts, customer service, and other forms of after-sales support. The Nanofabrication segment manufactures and supplies nanoproducts, which are used by its customers as components for the smooth functioning and performance of various parts of their end-products. The company is also involved in the marketing and sale of industrial machinery and equipment; research and experimental development on engineering; research and development, engineering, and production hydrogen application and products; manufacture and supply of dies, moulds, tools, jigs, and fixtures; and provision of coating services to end users in the precision engineering and printed circuit boards industry, as well as coating services for precision components and automotive parts. In addition, it engages in solar cell business; the provision of consultation and technical development services; the manufacture and forming of modules; manufacture, processing, and assembly of plastic products; production and sale of auto parts; and trading and sale of electronics and equipment. The company was incorporated in 1999 and is headquartered in Singapore.
Full NNFTF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.